University of Tübingen-ko ikertzaileekin lankidetzan egindako argitalpenak (10)

2023

  1. The clinical and molecular taxonomy of t(14;18)-negative follicular lymphomas

    Blood Advances, Vol. 7, Núm. 18, pp. 5258-5271

2022

  1. A unifying hypothesis for PNMZL and PTFL: morphological variants with a common molecular profile

    Blood Advances, Vol. 6, Núm. 16, pp. 4661-4674

  2. Diffuse large B-cell lymphomas in adults with aberrant coexpression of CD10, BCL6, and MUM1 are enriched in IRF4 rearrangements

    Blood Advances, Vol. 6, Núm. 7, pp. 2361-2372

  3. The molecular hallmarks of primary and secondary vitreoretinal lymphoma

    Blood Advances, Vol. 6, Núm. 5, pp. 1598-1607

2021

  1. Author Correction: Genetic landscape of 6089 inherited retinal dystrophies affected cases in Spain and their therapeutic and extended epidemiological implications (Scientific Reports, (2021), 11, 1, (1526), 10.1038/s41598-021-81093-y)

    Scientific Reports

  2. Genetic landscape of 6089 inherited retinal dystrophies affected cases in Spain and their therapeutic and extended epidemiological implications

    Scientific Reports, Vol. 11, Núm. 1

  3. MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma

    Haematologica, Vol. 106, Núm. 10, pp. 2682-2693

2019

  1. CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D12 mantle cell lymphoma

    Blood, Vol. 133, Núm. 9, pp. 940-951

2014

  1. A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma

    Blood, Vol. 123, Núm. 8, pp. 1187-1198

2011

  1. Gray zone lymphoma: Chromosomal aberrations with immunophenotypic and clinical correlations

    Modern Pathology, Vol. 24, Núm. 12, pp. 1586-1597